Both compounds ameliorated renal fibrosis and suppressed ferroptosis by downregulation Fe2+, TFR1, and ROS levels, while concurrently upregulating the decreased levels of SLC7A11 and GPX4 (Tan et al., 2022) (Wang et al., 2023). Here, GPX4 is linked to renal fibrosis.